Journal of the Saudi Heart Association · 2016 · 13 citations · 4 references
MedicineCardiologyHematologyCardiovascular PharmacotherapyClinical CardiologyImmunopathologyEosinophilic DisordersHeart FailureEosinophilic Disease TherapyEosinophilic InfiltratesEosinophilic MyocarditisFibrosis In Eosinophilic DiseaseHypereosinophilic SyndromeInflammatory Tissue DamageVisceral Involvement
Hypereosinophilic syndrome (HES) is a heterogeneous group of hematological disorders characterized by a chronic, unexplained hypereosinophilia with tissue damage. Cardiac involvement occurs in ∼20% of patients with HES and represents a major turning point. Cardiac injuries related to eosinophilia are divided into three chronological phases: eosinophilic infiltration, thrombosis, and fibrosis. We report a case of a 33-year-old woman diagnosed with HES, with pulmonary and gastrointestinal involvement and eosinophilic myocarditis in cardiogenic shock. The evolution was favorable with dobutamine, anticoagulation, corticosteroids, and later, β-blockers and angiotensin-converting enzyme inhibitors. Cardiac involvement in HES is rare but carries a poor prognosis. Corticosteroids are considered by many to be the mainstay of treatment. Although new treatments have been suggested, only a few seem promising.
4
The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.
Michael J. Chusid, David C. Dale, Burton C. West et al. · PubMed · 1975 · 1.2K citations
Medicine, Hematology, Pathology +14
THE HYPEREOSINOPHILIC SYNDROME
Michael J. Chusid, David C. Dale, Burton C. West et al. · Medicine · 1975 · 1.1K citations
Princess U. Ogbogu, Bruce S. Bochner, Joseph H. Butterfield et al. · Journal of Allergy and Clinical Immunology · 2009 · 621 citations · Full text
Eosinophilic myocarditis: case series and literature review
Kyoung‐Hee Sohn, Woo‐Jung Song, Byung‐Keun Kim et al. · Asia Pacific Allergy · 2015 · 15 citations
Medicine, Cardiology, Pathology +13